Patients should feel empowered to ask direct questions: "Will this medication affect my ability to get pregnant?" "When should I stop this medication if I want to conceive?" "What contraception do you recommend while I'm taking this?" "Are there fertility tests I should have before starting?" Open communication ensures that treatment decisions align with individual reproductive goals and timelines, supporting both metabolic health and family planning objectives
Mar 27, 2026 Timing is perfect
At IUVENTUS, semaglutide is prescribed as part of a physician-supervised program weekly injections combined with guidance on exercise and a reduced-calorie diet
Your provider may recommend anti-nausea medication, suggest timing adjustments for your injection, or discuss alternative formulations if injectable semaglutide proves too challenging
Novo Nordisk, the parent company of Wegovy, told Newsweek that this study "highlights the chronic nature of obesity and suggest that ongoing treatment is necessary." Eli Lilly and Company, the parent company of Mounjaro, told Newsweek : "When treatment is stopped, weight can return, which reflects the biology of the condition rather than a lack of effort." Newsweek reached out to the Centers for Disease Control and Prevention (CDC) via email for comment
